Diabetes and high blood pressure are the most prevalent causes of kidney disease. Patients with end stage kidney disease require their blood to be routinely filtered externally through haemodialysis.
Globally, the number of patients with kidney failure grows by 6% annually, resulting in an estimated 4.9 million patients in 2025.
For the last 50 years, open surgery has been the current gold standard for preparing patients for dialysis. This involves suturing together an artery and vein in the forearm to create a vascular access site (Arteriovenous Fistula or AVF) for the dialysis machine to connect to.
surgical AVF creations per year
An AVF is a patient's lifeline and is crucial to receiving dialysis treatment. High failure rates of surgical AVFs result in multiple repeat salvage procedures.
Surgical
Failure
1 year
patient
Per patient year
Time to heal and mature
per salvage procedure
US yearly spend on failing
dialysis access sites
The ePATH endoAVF system aims to reduce the burden on patients and healthcare systems through a more reliable alternative to surgical AVF creation.
Diabetes is also a major cause of peripheral arterial disease.
A Chronic Total Occlusion (CTO) is the most severe stage of the disease and presents a serious risk of amputation due to the complete lack of blood flow.
amputations p.a. in the US and UK
with most advanced
stage (CTO)
Average
Re-entry
Success Rate
The ePATH Re-Entry catheter kit will provide clinicians with a safer, more precise, and more reliable approach to CTO True Lumen Re-entry procedures.
1 Square Rigger Row, London SW11 3TZ, UK
Not available for sale in the United States © 2023 Stent Tek Ltd
Pathfinder Medical is the trading name of Stent Tek Ltd. Company No. 09289469
